The UK-PBC platform is a unique resource that will allow interested parties to access appropriate numbers of patients in a reasonable time-period in order to conduct clinical trials of second-line therapy. Ethical approval has recently been granted to allow the UK-PBC team to identify patients that may be eligible for follow on studies.
For more information about accessing this resource, visit the Data Access page of this website.
This section provides information about the projects being undertaken through UK-PBC in the following areas:
